SIFI, AKANTIOR®

SIFI recibe la designación de medicamento innovador prometedor para AKANTIOR®

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

SIFI S.p.A. Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

View original content:https://www.prnewswire.com/news-releases/sifi-recibe-la-designacion-de-medicamento-innovador-prometedor-para-akantior-302458912.html

en | boerse | 67927309 |